The pharmaceutical industry continues its full-court press opposition to a prescription price reduction plan proposed by House Speaker Nancy Pelosi.

Life sciences organizations are marshaling their forces in opposition to Nancy Pelosi’s drug pricing reform bill.

PhRMA CEO Stephen Ubl said House Speaker Nancy Pelosi’s plan would be “devastating” to the industry.